Add BrightSurf on Google Email

Science News Archive September 2009 - Page 24


Page 24 of 24

Innovative therapies for treatment of post-traumatic stress disorder

Researchers develop virtual environments and novel medicines to help military personnel diagnosed with PTSD, and explore the use of psychiatric service dogs. Preliminary data from clinical trials show promising results in treating co-morbid alcohol dependence.

SourceUS Department of Defense Congressionally Directed Medical Research Programs·DateSep 1, 2009

Patient perception is vital when reporting medical errors

Patients' perceptions of what was said by the physician were more important than what was actually said. A full apology and acceptance of responsibility by the physician in error led to better ratings and greater trust among viewers. However, this did not significantly affect the likelihood of patients suing physicians.

SourceJohns Hopkins Bloomberg School of Public Health·JournalJournal of General Internal Medicine·DateSep 1, 2009
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Super-fast computers of the future receive funding boost

A new £6 million research programme aims to develop nanoplasmonic devices that can process information using light signals, potentially leading to faster data processing speeds. The project, funded by the EPSRC, is being conducted at Queen's University Belfast and Imperial College London.

SourceImperial College London·DateSep 1, 2009

Inflammatory disease treatments will improve through the use of lipidomics

Researchers at the University of Missouri have completed a comprehensive analysis of bioactive lipids in an inflammatory response triggered by Lyme disease. The study found correlations between eicosanoid levels and arthritis severity, paving the way for diagnostic tools, personalized therapies, and more effective treatments.

SourceUniversity of Missouri-Columbia·JournalJournal of Biological Chemistry·DateSep 1, 2009

From fat to chronic inflammation

A new study reveals that angiopoietin-like protein 2 (Angptl2) is a primary contributor to chronic inflammation in fat tissue, exacerbating conditions like diabetes and cardiovascular disease. Elevated Angptl2 levels have been found in obese individuals and those with insulin resistance.

SourceCell Press·JournalCell Metabolism·DateSep 1, 2009

Medical home gives patients better primary care at no more cost

A one-year evaluation demonstrates the benefits of the patient-centered medical home model, which provides personalized care, prevention, and coordination. The study found significantly fewer emergency room visits and hospitalizations among patients with access to a medical home.

SourceGroup Health Research Institute·JournalThe American Journal of Managed Care·DateSep 1, 2009
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

Getting better visualization of joint cartilage through cationic CT contrast agents

Researchers at Boston University have developed new computer tomography contrast agents that selectively bind to glycosaminoglycans in articular cartilage, improving visualization and sensitivity for diagnosing osteoarthritis. The study's findings show that these cationic agents are three times more sensitive than current contrast agents.

SourceBoston University School of Medicine·JournalJournal of the American Chemical Society·DateSep 1, 2009

Immediate intervention for patients with ACS not always more beneficial

A new study published in JAMA suggests that immediate intervention for patients with acute coronary syndromes (ACS) may not provide a significant advantage in terms of outcomes. However, the strategy can still reduce hospital stay duration. The study evaluated data from 352 patients with ACS and found that both immediate and delayed in...

SourceJAMA Network·JournalJAMA·DateSep 1, 2009

Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs

Researchers from Thomas Jefferson University developed a prodrug that could potentially reduce or avoid skin toxicity associated with EGFR-inhibiting cancer drugs. The prodrug is designed to preferentially bind to tumor tissue, reducing side effects. By targeting the tumor site, the prodrug can minimize damage to normal tissues.

SourceThomas Jefferson University·JournalCancer Biology & Therapy·DateSep 1, 2009
Sky & Telescope Pocket Sky Atlas, 2nd Edition

Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.